These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


318 related items for PubMed ID: 13950

  • 1. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.
    O'Brien JS, Norden GW, Miller AL, Frost RG, Kelly TE.
    Clin Genet; 1977 Mar; 11(3):171-83. PubMed ID: 13950
    [Abstract] [Full Text] [Related]

  • 2. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
    Conzelmann E, Kytzia HJ, Navon R, Sandhoff K.
    Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
    [Abstract] [Full Text] [Related]

  • 3. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
    Erzberger A, Conzelmann E, Sandhoff K.
    Clin Chim Acta; 1980 Dec 22; 108(3):361-8. PubMed ID: 6781795
    [Abstract] [Full Text] [Related]

  • 4. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E, Sandhoff K.
    Proc Natl Acad Sci U S A; 1978 Aug 22; 75(8):3979-83. PubMed ID: 99746
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of Tay-Sachs disease using [3H]N-acetylneuraminic acid labelled GM2 ganglioside as substrate.
    Poulos A, Holding J, Carey WF.
    Clin Chim Acta; 1982 Apr 23; 120(3):331-40. PubMed ID: 6210469
    [Abstract] [Full Text] [Related]

  • 6. Characterization of unusual hexosaminidase A (HEX A) deficient human mutants.
    O'Brien JS, Tennant L, Veath ML, Scott CR, Bucknall WE.
    Am J Hum Genet; 1978 Nov 23; 30(6):602-8. PubMed ID: 747188
    [Abstract] [Full Text] [Related]

  • 7. Assay of the GM2-ganglioside cleaving hexosaminidase activity of skin fibroblasts for GM2-gangliosidoses.
    Harzer K.
    Clin Chim Acta; 1983 Nov 30; 135(1):89-93. PubMed ID: 6228344
    [No Abstract] [Full Text] [Related]

  • 8. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
    Charrow J, Binns HJ.
    Clin Chim Acta; 1986 Apr 15; 156(1):41-9. PubMed ID: 2938852
    [Abstract] [Full Text] [Related]

  • 9. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E, Nehrkorn H, Kytzia HJ, Sandhoff K, Macek M, Lehovský M, Elleder M, Jirásek A, Kobilková J.
    Pediatr Res; 1985 Nov 15; 19(11):1220-4. PubMed ID: 2933632
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P, Gordon BA, Ng Ying Kin NM.
    Pediatr Res; 1982 Mar 15; 16(3):217-22. PubMed ID: 6801612
    [Abstract] [Full Text] [Related]

  • 12. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
    Conzelmann E, Sandhoff K.
    Adv Exp Med Biol; 1980 Mar 15; 125():295-306. PubMed ID: 6444774
    [Abstract] [Full Text] [Related]

  • 13. GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.
    Raghavan SS, Krusell A, Krusell J, Lyerla TA, Kolodny EH.
    Am J Hum Genet; 1985 Nov 15; 37(6):1071-82. PubMed ID: 2934978
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incorporation and metabolism of ganglioside GM2 in skin fibroblasts from normal and GM2 gangliosidosis subjects.
    Sonderfeld S, Conzelmann E, Schwarzmann G, Burg J, Hinrichs U, Sandhoff K.
    Eur J Biochem; 1985 Jun 03; 149(2):247-55. PubMed ID: 3922757
    [Abstract] [Full Text] [Related]

  • 16. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
    Hechtman P.
    Can J Biochem; 1977 Apr 03; 55(4):315-24. PubMed ID: 858083
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evidence for two different active sites on human beta-hexosaminidase A. Interaction of GM2 activator protein with beta-hexosaminidase A.
    Kytzia HJ, Sandhoff K.
    J Biol Chem; 1985 Jun 25; 260(12):7568-72. PubMed ID: 3158659
    [Abstract] [Full Text] [Related]

  • 20. Plasma GM2 ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-Gangliosidosis.
    Blondel A, Kraoua I, Marcelino C, Khrouf W, Schlemmer D, Ganne B, Caillaud C, Fernández-Eulate G, Turki IBY, Dauriat B, Bonnefont-Rousselot D, Nadjar Y, Lamari F.
    Mol Genet Metab; 2023 Feb 25; 138(2):106983. PubMed ID: 36709536
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.